ERα phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells

Lung Cancer

Volumn 75, Issue 3, 2012, Pages 285-292

  Lin, Susana ^a   Lin, Chun Ju ^a   Hsieh, Dennis P H ^a   Li, Lih Ann ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Benzo a pyrene; ER ; Estrogen metabolism; Gene regulation; Lung adenocarcinoma; Tumor growth

Indexed keywords

2 METHOXYESTRADIOL; 4 HYDROXYESTRADIOL; BENZO[A]PYRENE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN METABOLISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR XENOGRAFT; UPREGULATION;

ADENOCARCINOMA; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; OVARIECTOMY; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856564293     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.08.010     Document Type: Article

References (41)

1. Koo L.C., Ho J.H. Worldwide epidemiological patterns of lung cancer in nonsmokers. Int J Epidemiol 1990, 19(Suppl. 1):S14-S23.
2. Liaw Y.P., Huang Y.C., Lien G.W. Patterns of lung cancer mortality in 23 countries: application of the age-period-cohort model. BMC Public Health 2005, 5:22.
3. Siegfried J.M. Women and lung cancer: does oestrogen play a role?. Lancet Oncol 2001, 2:506-513.
4. Bain C., Feskanich D., Speizer F.E., Thun M., Hertzmark E., Rosner B.A., et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004, 96:826-834.
5. Radzikowska E., Glaz P., Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20561 cases. Ann Oncol 2002, 13:1087-1093.
6. Wakelee H.A., Chang E.T., Gomez S.L., Keegan T.H., Feskanich D., Clarke C.A., et al. Lung cancer incidence in never smokers. J Clin Oncol 2007, 25:472-478.
7. Taioli E., Wynder E.L. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994, 86:869-870.
8. Morani A., Warner M., Gustafsson J.A. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J Intern Med 2008, 264:128-142.
9. Ali G., Donati V., Loggini B., Servadio A., Dell'Omodarme M., Prati M.C., et al. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol 2008, 39:1465-1473.
10. Kawai H., Ishii A., Washiya K., Konno T., Kon H., Yamaya C., et al. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 2005, 11:5084-5089.
11. Nose N., Sugio K., Oyama T., Nozoe T., Uramoto H., Iwata T., et al. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung. J Clin Oncol 2009, 27:411-417.
12. Omoto Y., Kobayashi Y., Nishida K., Tsuchiya E., Eguchi H., Nakagawa K., et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun 2001, 285:340-347.
13. Schwartz A.G., Prysak G.M., Murphy V., Lonardo F., Pass H., Schwartz J., et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005, 11:7280-7287.
14. Wu C.T., Chang Y.L., Shih J.Y., Lee Y.C. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005, 130:979-986.
15. Olivo-Marston S.E., Mechanic L.E., Mollerup S., Bowman E.D., Remaley A.T., Forman M.R., et al. Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis 2010, 31:1778-1786.
16. Raso M.G., Behrens C., Herynk M.H., Liu S., Prudkin L., Ozburn N.C., et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res 2009, 15:5359-5368.
17. Fasco M.J., Hurteau G.J., Spivack S.D. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002, 188:125-140.
18. Kaiser U., Hofmann J., Schilli M., Wegmann B., Klotz U., Wedel S., et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 1996, 67:357-364.
19. Mueller M.D., Vigne J.L., Minchenko A., Lebovic D.I., Leitman D.C., Taylor R.N. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA 2000, 97:10972-10977.
20. Zhang G., Liu X., Farkas A.M., Parwani A.V., Lathrop K.L., Lenzner D., et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol 2009, 23:146-156.
21. Tsuchiya Y., Nakajima M., Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005, 227:115-124.
22. Waxman D.J., Holloway M.G. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009, 76:215-228.
23. Armstrong B., Hutchinson E., Unwin J., Fletcher T. Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect 2004, 112:970-978.
24. Friesen M.C., Demers P.A., Spinelli J.J., Lorenzi M.F., Le N.D. Comparison of two indices of exposure to polycyclic aromatic hydrocarbons in a retrospective aluminium smelter cohort. Occup Environ Med 2007, 64:273-278.
25. Nebert D.W., Dalton T.P., Okey A.B., Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 2004, 279:23847-23850.
26. Charles G.D., Bartels M.J., Zacharewski T.R., Gollapudi B.B., Freshour N.L., Carney E.W. Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. Toxicol Sci 2000, 55:320-326.
27. Safe S., Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 2003, 16:807-816.
28. Green S., Issemann I., Sheer E. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 1988, 16:369.
29. Chu Y.W., Yang P.C., Yang S.C., Shyu Y.C., Hendrix M.J., Wu R., et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997, 17:353-360.
30. Lin T.C., Chien S.C., Hsu P.C., Li L.A. Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. Endocrinology 2006, 147:1536-1544.
31. Li L.A., Wang P.W., Chang L.W. Polychlorinated biphenyl 126 stimulates basal and inducible aldosterone biosynthesis of human adrenocortical H295R cells. Toxicol Appl Pharmacol 2004, 195:92-102.
32. Fitzgerald D.J., Robinson N.I., Pester B.A. Application of benzo(a)pyrene and coal tar tumor dose-response data to a modified benchmark dose method of guideline development. Environ Health Perspect 2004, 112:1341-1346.
33. Sengupta K., Banerjee S., Saxena N., Banerjee S.K. Estradiol-induced vascular endothelial growth factor-a expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Int J Oncol 2003, 22:609-614.
34. Tsuchiya Y., Nakajima M., Kyo S., Kanaya T., Inoue M., Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004, 64:3119-3125.
35. Gerstner S., Glasemann D., Pfeiffer E., Metzler M. The influence of metabolism on the genotoxicity of catechol estrogens in three cultured cell lines. Mol Nutr Food Res 2008, 52:823-829.
36. Majidi M., Al-Wadei H.A., Takahashi T., Schuller H.M. Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells. Cancer Res 2007, 67:6863-6871.
37. Roy D., Weisz J., Liehr J.G. The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen-induced carcinogenesis. Carcinogenesis 1990, 11:459-462.
38. Dietrich C., Kaina B. The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 2010, 31:1319-1328.
39. Marlowe J.L., Puga A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 2005, 96:1174-1184.
40. Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002, 20:4368-4380.
41. Horvath G., Leser G., Helou K., Henriksson M. Function of the exon 7 deletion variant estrogen receptor alpha protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice. Gynecol Oncol 2002, 84:271-279.